1.
Radiolabeled Peptide as Diagnostic, Therapeutic, and Theranostic agents for Prostate Cancer: Systematic Literature Review. PharmRep [Internet]. 2022 Mar. 2 [cited 2026 Nov. 20];1(1). Available from: https://jurnal.umi.ac.id/index.php/PharmRep/article/view/174